Nexstim Receives an NBS System Order from a Hospital in Germany
Press release, Helsinki, December 8,2021at 11:30 AM(EET)
Nexstim Receives an NBS System Order from a Hospital in Germany
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having received a new system order from a hospital in Germany.
The customer is new to Nexstim. The order consists of an NBS system that includes the software of an NBT® system. Nexstim’s NBS system is CE marked for pre-surgical mapping of the speech and motor cortices of the brain, and the NBT® system for the treatment of major depression and chronic neuropathic pain.
Mikko Karvinen, CEO of Nexstim, comments: “We are excited to welcome this hospital to our user community. Happy to see the increasinginterest thatour customers have shown this year in using the same system for both diagnostic and therapeutic applications.“
Further information is available on the website www.nexstim.com, or by contacting:
Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com
About Nexstim Plc
Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim’s Therapy Business markets and sells the Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.
Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.
For more information, please visit www.nexstim.com
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Ensurge Micropower ASA - Grant of Incentive Subscription Rights24.4.2024 23:30:00 CEST | Press release
The Board of Directors of Ensurge Micropower ASA (the "Company") resolved on 24 April 2024 to issue a total of 202,200 incentive subscription rights to employees in the Ensurge group. The grants were made under the Company's 2023 incentive subscription rights plan, as resolved at the Annual General Meeting on 24 May 2023, and amended on the Extraordinary General Meeting held on 10 November 2023. The exercise price of the subscription rights is calculated to NOK 1.2640 per share. The subscription rights expire on 24 May 2028. The subscription rights follow the terms and conditions of the 2023 subscription rights incentive plan. Following the grant there are 46,057,881 incentive subscription rights issued and outstanding in the Company. For more information, please contact: Lars Eikeland, Chief Executive Officer E- mail: lars.eikeland@ensurge.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Bombardier Unveils Bold New Brand Identity Worldwide as Company Soars Toward an Ambitious Future24.4.2024 23:12:07 CEST | Press release
A new logo celebrates the company’s successful shift toward pure-play business aviation. The symbol itself, the Bombardier Mach, features the silhouette of an aircraft breaking the sound barrier, while the strokes of wind over a wing reference the company’s heritageThe employee value proposition “where heart meets mastery” focuses on Bombardier’s talented people, celebrating the workforce’s renowned passion, its incredible craftsmanship and profound technological expertise MONTRÉAL, April 24, 2024 (GLOBE NEWSWIRE) -- Bombardier, the worldwide leader in business aviation, today unveiled a new brand identity anchored by the evolution of the company’s logo. As Bombardier successfully moves forward as a company with a sole focus on designing, building and servicing the world’s best business jets, the new brand identity will reinforce and propel the company’s unique approach to its customers and stakeholders—putting people at the centre and instilling a one-of-a-kind sense of family. Bombar
Vistin Pharma ASA: Annual Report 202324.4.2024 23:10:00 CEST | Press release
Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 16 February 2024. The annual report for 2024 will also be made available on www.vistin.com. ***** For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 Alexander.karlsen@vistin.com Attachments 2023 Annual Report Vistin Pharma ASAVistinpharmaasa-2023-12-31-en
Nokia Corporation: Repurchase of own shares on 24.04.202424.4.2024 21:30:00 CEST | Press release
Nokia Corporation Stock Exchange Release 24 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.04.2024 Espoo, Finland – On 24 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL392,1193.43CEUX--BATE--AQEU--TQEX--Total392,1193.43 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of
Sveitarfélagið Árborg – Ársreikningur 202324.4.2024 20:40:35 CEST | Press release
Ársreikningur Sveitarfélagsins Árborgar fyrir árið 2023 var lagður fram í bæjarráði og til fyrri umræðu á fundi bæjarstjórnar í dag miðvikudaginn 24.04.2024. Rekstrarniðurstaða Sveitarfélagsins Árborg samkvæmt samanteknum rekstrarreikningi A og B hluta var neikvæð um 1.269 millj.kr. en samkvæmt samþykktri fjárhagsáætlun fyrir árið 2023 var gert ráð fyrir 1.855 mill.kr. neikvæðri rekstrarniðurstöðu. Uppfærð fjárhagsáætlun ársins 2023 gerði ráð fyrir 1.693 millj.kr. neikvæðri niðurstöðu. Tekjur ársins af A og B hluta námu alls 17.951 millj.kr., launakostnaður 9.686 millj.kr., hækkun lífeyrisskuldbindinga nam 658 millj.kr.. Annar rekstrarkostnaður var 5.622 millj.kr. og nemur framlegð því 1.984 millj.kr. Afskriftir voru 951 millj.kr.. Fjármunatekjur, fjármagnsgjöld og tekjuskattur námu 2.302 millj.kr. og var rekstrarniðurstaða ársins því neikvæð um 1.269 millj.kr. Veltufé frá rekstri var 1.713 millj.kr. eða 9,5% af heildartekjum A og B hluta. Skuldahlutfall hefur lækkað á árinu 2023 og er